Study further validates highly reproducible drug response data. Enables AI platform to model and predict patient outcomes on historical samples Global…
Company to highlight 4D-150 product development strategy and Phase 1/2 PRISM clinical trial data in wet age-related macular degeneration (wet…
Partnership with the European patient advocacy group furthers myTomorrows' mission to expand access to all possible treatment options for patients…
LUND, SE / ACCESSWIRE / August 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported currently…
Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI TOKYO, Aug. 26, 2024…
Infor CloudSuite Healthcare to Better Link People to Processes NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Infor, the industry cloud…
Embarking on a journey to ultimately becoming AI's nose capable of digitizing smellAI Nose journey begins in healthcare and is…
Study Highlights Superior Efficacy of Ketamir-2 Over Oral Ketamine, Achieving Full Normalization of Pain ThresholdsMIAMI, FL / ACCESSWIRE / August…
SHELTON, CT / ACCESSWIRE / August 26, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader…
PASADENA, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”),…